Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

LOGIN HERE

Cancel

BSE Code : 532531 | NSE Symbol : STAR | ISIN : INE939A01011 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |

Profit and Loss

Particulars (₹ Cr)	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Revenue From Operations	2,153.26	1,854.50	1,979.00	1,857.57	1,691.93
Sale of Products	2,048.17	1,745.16	1,908.03	1,776.54	1,541.10
Sale of Services	14.06	17.27	11.19	18.92	9.51
Income from Investment and Financial Services	0.00	0.00	0.00	0.00	0.00
Income from Insurance Operations	0.00	0.00	0.00	0.00	0.00
Other Operating Revenue	91.02	92.06	59.79	62.11	141.32
Less: Excise Duty / GST	0.00	0.00	0.00	0.00	0.00
Revenue From Operations - Net	2,153.26	1,854.50	1,979.00	1,857.57	1,691.93
Other Income	72.31	84.07	123.49	117.09	93.07
Total Revenue	2,225.56	1,938.56	2,102.49	1,974.65	1,785.00
Changes in Inventories	4.62	21.04	114.26	-117.53	-2.88
Cost of Material Consumed	1,072.63	1,020.10	935.42	1,050.10	857.44
Internally Manufactured Intermediates Consumed	0.00	0.00	0.00	0.00	0.00
Purchases of Stock-in-Trade	29.23	24.47	51.83	56.31	37.40
Employee Benefits	335.21	267.01	272.09	272.72	230.23
Total Other Expenses	456.30	423.40	528.77	436.74	365.28
Manufacturing / Operating Expenses	197.95	175.57	195.63	180.68	161.96
Administrative and Selling Expenses	168.38	182.64	260.83	171.51	117.95
Other Expenses	89.97	65.19	72.31	84.56	85.37
Finance Costs	167.93	138.68	74.24	65.34	66.84
Depreciation and Amortization	84.67	93.62	104.37	99.34	94.24
Total Expenses	2,150.58	1,988.32	2,080.98	1,863.02	1,648.56
Profit Before Exceptional Items and Tax	74.99	-49.76	21.51	111.64	136.45
Exceptional Items Before Tax	-5.37	-15.00	0.00	0.00	0.00
Profit Before Extraordinary Items and Tax	69.62	-64.76	21.51	111.64	136.45
Extraordinary Items Before Tax	0.00	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	69.62	-64.76	21.51	111.64	136.45
Taxation	4.13	-69.44	-158.68	33.40	16.17
Current Tax	0.31	-49.84	2.09	21.02	15.20
MAT Credit Entitlement	0.00	0.00	-11.19	12.63	3.56
Deferred Tax	3.82	-19.60	10.98	-0.26	-2.59
Other Tax	0.00	0.00	0.00	0.00	0.00
Adjust for Previous Year	0.00	0.00	-160.56	0.00	0.00
Profit After Tax	65.49	4.68	180.19	78.24	120.28
Extraordinary Items After Tax	0.00	0.00	0.00	0.00	0.00
Discontinued Operations After Tax	0.00	0.00	0.00	0.00	0.00
Profit / (Loss) from Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Tax Expenses of Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Shareholders	65.49	4.68	180.19	78.24	120.28
Adjustments to Net Income	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Equity Shareholders	65.49	4.68	180.19	78.24	120.28
Earning Per Share - Basic	7.20	0.52	20.08	8.73	13.43
Earning Per Share - Diluted	7.19	0.52	20.08	8.72	13.43

LOGIN HERE

LOGIN HERE

Strides Pharma Science Ltd

Profit and Loss